Phapros Tbk. vs Reksa Dana Indeks Cipta ETF Index LQ45 — how do they compare? Phapros Tbk. trades at Rp254 (market cap 220.08B, 204.7K 24h volume), while Reksa Dana Indeks Cipta ETF Index LQ45 trades at Rp67 (market cap 8.12B, 27K 24h volume). The key difference: Phapros Tbk. is far larger — about 27.1× Reksa Dana Indeks Cipta ETF Index LQ45's market cap, and Phapros Tbk. is more actively traded (204.7K versus 27K). Which is the better fit depends on your goals.
| PEHA | XCLQ | |
|---|---|---|
Market Cap | 220.08B | 8.12B |
Volume | 204.7K | 27K |
Lot | 2.05K | 270 |
Turnover | 52.61M | 2.03M |
Average Price | 256.99 | 75.04 |
Value | 52.61M | 2.03M |
Trailing returns across standard periods
Latest headlines on both assets
PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →